Chandwe, Kanta
Bwakura-Dangarembizi, Mutsa
Amadi, Beatrice
Tawodzera, Gertrude
Ngosa, Deophine
Dzikiti, Anesu
Chulu, Nivea
Makuyana, Robert
Zyambo, Kanekwa http://orcid.org/0000-0001-5686-5319
Mutasa, Kuda
Mulenga, Chola
Besa, Ellen http://orcid.org/0000-0001-5606-9435
Sturgeon, Jonathan P. http://orcid.org/0000-0003-1318-1739
Mudzingwa, Shepherd
Simunyola, Bwalya
Kazhila, Lydia
Zyambo, Masuzyo
Sonkwe, Hazel
Mutasa, Batsirai
Chipunza, Miyoba
Sauramba, Virginia
Langhaug, Lisa http://orcid.org/0000-0002-9131-8158
Mudenda, Victor
Murch, Simon H. http://orcid.org/0000-0002-3870-8229
Hill, Susan
Playford, Raymond J. http://orcid.org/0000-0003-1235-8504
VanBuskirk, Kelley http://orcid.org/0009-0004-9110-9059
Prendergast, Andrew J. http://orcid.org/0000-0001-7904-7992
Kelly, Paul http://orcid.org/0000-0003-0844-6448
Funding for this research was provided by:
RCUK | Medical Research Council (MR/P024033/1)
Wellcome Trust (108065/Z/15/Z, 220566/Z/20/Z)
Article History
Received: 28 April 2023
Accepted: 26 January 2024
First Online: 17 April 2024
Competing interests
: RJP was previously an external consultant to Colostrum UK which provided the bovine colostrum used in these studies. RJP has also been an external consultant to Sterling Technology (USA) and an employee of Pantheryx Inc (USA) who produce and distribute bovine colostrum. There was no bovine colostrum company involvement in the production of this article or editing of its content. SH has had funding for teduglutide studies and lectured and participated in advisory boards on behalf of Takeda. The remaining authors declare no competing interests.